Works in EMBO Molecular Medicine, 2022, Vol 14, Issue 3

Results: 14
    1
    2

    Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.

    Published in:
    EMBO Molecular Medicine, 2022, v. 14, n. 3, p. 1, doi. 10.15252/emmm.202115618
    By:
    • Ye, Liping;
    • Lin, Chuyong;
    • Wang, Xi;
    • Li, Qiji;
    • Li, Yue;
    • Wang, Meng;
    • Zhao, Zekun;
    • Wu, Xianqiu;
    • Shi, Dongni;
    • Xiao, Yunyun;
    • Ren, Liangliang;
    • Jian, Yunting;
    • Yang, Meisongzhu;
    • Ou, Ruizhang;
    • Deng, Guangzheng;
    • Ouyang, Ying;
    • Chen, Xiangfu;
    • Li, Jun;
    • Song, Libing
    Publication type:
    Article
    3
    4
    5

    Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection.

    Published in:
    EMBO Molecular Medicine, 2022, v. 14, n. 3, p. 1, doi. 10.15252/emmm.202115227
    By:
    • Tay, Matthew Zirui;
    • Rouers, Angeline;
    • Fong, Siew‐Wai;
    • Goh, Yun Shan;
    • Chan, Yi‐Hao;
    • Chang, Zi Wei;
    • Xu, Weili;
    • Tan, Chee Wah;
    • Chia, Wan Ni;
    • Torres‐Ruesta, Anthony;
    • Amrun, Siti Naqiah;
    • Huang, Yuling;
    • Hor, Pei Xiang;
    • Loh, Chiew Yee;
    • Yeo, Nicholas Kim‐Wah;
    • Wang, Bei;
    • Ngoh, Eve Zi Xian;
    • Salleh, Siti Nazihah Mohd;
    • Chavatte, Jean‐Marc;
    • Lim, Alicia Jieling
    Publication type:
    Article
    6
    7

    Compound heterozygous variants in OTULIN are associated with fulminant atypical late‐onset ORAS.

    Published in:
    EMBO Molecular Medicine, 2022, v. 14, n. 3, p. 1, doi. 10.15252/emmm.202114901
    By:
    • Zinngrebe, Julia;
    • Moepps, Barbara;
    • Monecke, Thomas;
    • Gierschik, Peter;
    • Schlichtig, Ferdinand;
    • Barth, Thomas F E;
    • Strauß, Gudrun;
    • Boldrin, Elena;
    • Posovszky, Carsten;
    • Schulz, Ansgar;
    • Beringer, Ortraud;
    • Rieser, Eva;
    • Jacobsen, Eva‐Maria;
    • Lorenz, Myriam Ricarda;
    • Schwarz, Klaus;
    • Pannicke, Ulrich;
    • Walczak, Henning;
    • Niessing, Dierk;
    • Schuetz, Catharina;
    • Fischer‐Posovszky, Pamela
    Publication type:
    Article
    8
    9

    Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma.

    Published in:
    EMBO Molecular Medicine, 2022, v. 14, n. 3, p. 1, doi. 10.15252/emmm.202115295
    By:
    • Diazzi, Serena;
    • Baeri, Alberto;
    • Fassy, Julien;
    • Lecacheur, Margaux;
    • Marin‐Bejar, Oskar;
    • Girard, Christophe A;
    • Lefevre, Lauren;
    • Lacoux, Caroline;
    • Irondelle, Marie;
    • Mounier, Carine;
    • Truchi, Marin;
    • Couralet, Marie;
    • Ohanna, Mickael;
    • Carminati, Alexandrine;
    • Berestjuk, Ilona;
    • Larbret, Frederic;
    • Gilot, David;
    • Vassaux, Georges;
    • Marine, Jean‐Christophe;
    • Deckert, Marcel
    Publication type:
    Article
    10

    THEM6‐mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer.

    Published in:
    EMBO Molecular Medicine, 2022, v. 14, n. 3, p. 1, doi. 10.15252/emmm.202114764
    By:
    • Blomme, Arnaud;
    • Peter, Coralie;
    • Mui, Ernest;
    • Rodriguez Blanco, Giovanny;
    • An, Ning;
    • Mason, Louise M;
    • Jamieson, Lauren E;
    • McGregor, Grace H;
    • Lilla, Sergio;
    • Ntala, Chara;
    • Patel, Rachana;
    • Thiry, Marc;
    • Kung, Sonia H Y;
    • Leclercq, Marine;
    • Ford, Catriona A;
    • Rushworth, Linda K;
    • McGarry, David J;
    • Mason, Susan;
    • Repiscak, Peter;
    • Nixon, Colin
    Publication type:
    Article
    11

    The Sec61 translocon is a therapeutic vulnerability in multiple myeloma.

    Published in:
    EMBO Molecular Medicine, 2022, v. 14, n. 3, p. 1, doi. 10.15252/emmm.202114740
    By:
    • Domenger, Antoine;
    • Choisy, Caroline;
    • Baron, Ludivine;
    • Mayau, Véronique;
    • Perthame, Emeline;
    • Deriano, Ludovic;
    • Arnulf, Bertrand;
    • Bories, Jean‐Christophe;
    • Dadaglio, Gilles;
    • Demangel, Caroline
    Publication type:
    Article
    12

    A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.

    Published in:
    EMBO Molecular Medicine, 2022, v. 14, n. 3, p. 1, doi. 10.15252/emmm.202114552
    By:
    • Zhu, Lucía;
    • Retana, Diana;
    • García‐Gómez, Pedro;
    • Álvaro‐Espinosa, Laura;
    • Priego, Neibla;
    • Masmudi‐Martín, Mariam;
    • Yebra, Natalia;
    • Miarka, Lauritz;
    • Hernández‐Encinas, Elena;
    • Blanco‐Aparicio, Carmen;
    • Martínez, Sonia;
    • Sobrino, Cecilia;
    • Ajenjo, Nuria;
    • Artiga, Maria‐Jesus;
    • Ortega‐Paino, Eva;
    • Torres‐Ruiz, Raúl;
    • Rodríguez‐Perales, Sandra;
    • Soffietti, Riccardo;
    • Bertero, Luca;
    • Cassoni, Paola
    Publication type:
    Article
    13
    14